Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Mammary Gland Hyperplasia”

38 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 38 results

Not applicableStudy completedNCT01925586
What this trial is testing

Atypical Lesions of the Breast: Close Observation Versus Excision (ALCOVE)

Who this might be right for
Atypical Ductal Hyperplasia (ADH) of the Breast
Yale University 9
Not applicableUnknownNCT05868252
What this trial is testing

Molecular Analysis of the Sloane Project

Who this might be right for
DCISLCISAtypical Ductal Hyperplasia+1 more
King's College London 1,500
Large-scale testing (Phase 3)Active Not RecruitingNCT01905046
What this trial is testing

Metformin Hydrochloride in Preventing Breast Cancer in Patients With Atypical Hyperplasia or In Situ Breast Cancer

Who this might be right for
Atypical Ductal Breast HyperplasiaBRCA1 Mutation CarrierBRCA2 Mutation Carrier+2 more
Alliance for Clinical Trials in Oncology 86
Not applicableStudy completedNCT01975363
What this trial is testing

Pilot Study of Curcumin for Women With Obesity and High Risk for Breast Cancer

Who this might be right for
Atypical Ductal Breast HyperplasiaBRCA1 Gene MutationBRCA2 Gene Mutation+2 more
Ohio State University Comprehensive Cancer Center 29
Not applicableUnknownNCT01034891
What this trial is testing

Women At Risk: The High Risk Breast Cancer Program

Who this might be right for
Breast Cancer
New York Presbyterian Hospital 2,000
Testing effectiveness (Phase 2)Looking for participantsNCT05941520
What this trial is testing

Acolbifene Versus Low Dose Tamoxifen for the Prevention of Breast Cancer in Premenopausal Women at High Risk for Development of Breast Cancer

Who this might be right for
Breast Atypical HyperplasiaBreast CarcinomaBreast Ductal Carcinoma In Situ+1 more
National Cancer Institute (NCI) 80
Early research (Phase 1)Study completedNCT00637481
What this trial is testing

A Phase I Prevention Study of Atorvastatin in Women at Increased Risk for Breast Cancer

Who this might be right for
Atypical Ductal Breast HyperplasiaBreast CancerDuctal Breast Carcinoma in Situ+1 more
National Cancer Institute (NCI) 66
Not applicableStudy completedNCT00666731
What this trial is testing

Breast Cancer Registry for Participants With Breast Cancer or Characteristics of Hereditary Breast Cancer

Who this might be right for
Breast CancerPrecancerous Condition
University of Nebraska 4,945
Testing effectiveness (Phase 2)Study completedNCT00843167
What this trial is testing

Broccoli Sprout Extract in Treating Women Who Have Had a Mammogram and Breast Biopsy

Who this might be right for
Breast CancerPrecancerous Condition
OHSU Knight Cancer Institute 54
Early research (Phase 1)Study completedNCT01372644
What this trial is testing

Breast Cancer Chemoprevention by SOM230, an IGF-I Action Inhibitor: A Proof of Principle Trial

Who this might be right for
Atypical Ductal Breast HyperplasiaLobular Carcinoma in Situ (LCIS)Atypical Lobular Hyperplasia (ALH) of Breast
NYU Langone Health 15
Large-scale testing (Phase 3)Looking for participantsNCT06685978
What this trial is testing

Efficacy and Safety of Xiangjurupining Capsule for Hyperplasia of Mammary Glands

Who this might be right for
Hyperplasia of Mammary Glands
Tasly Pharmaceutical Group Co., Ltd 430
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07499999
What this trial is testing

Randomized Double-Blind Phase II Trial of Baby Exemestane Versus Baby Tamoxifen in Post-Menopausal Women at High Risk for Breast Cancer

Who this might be right for
Breast CancerDuctal CarcinomaEstrogen-receptor-positive Breast Cancer+4 more
Dana-Farber Cancer Institute 140
Not applicableStudy completedNCT00620087
What this trial is testing

Molecular Breast Imaging in Women With Atypia and LCIS

Who this might be right for
Atypical Lobular HyperplasiaAtypical Ductal HyperplasiaLobular Carcinoma in Situ
Mayo Clinic 66
Not applicableStudy completedNCT02121873
What this trial is testing

The Breast Duct: Pilot Study of Genomic Sequencing of Exfoliated Ductal Cells Obtained Through Endoscopy and Lavage

Who this might be right for
Breast CancerPreneoplastic ConditionsDuctal Carcinoma in Situ
Atossa Therapeutics, Inc. 6
Not applicableUnknownNCT02505256
What this trial is testing

Study Into Treatment of Hyperplasia of Mammary Glands

Who this might be right for
Hyperplasia
Shandong University 5,000
Post-approval studies (Phase 4)UnknownNCT02929420
What this trial is testing

A Clinical Study on the Efficacy and Safety of the Treatment of Hyperplasia of Mammary Glands With Xiaoru Sanjie Capsule

Who this might be right for
Fibrocystic Disease of Breast
First Affiliated Hospital Xi'an Jiaotong University 600
Not applicableUnknownNCT05932758
What this trial is testing

Excisional Vacuum-Assisted Breast Biopsy

Who this might be right for
Atypical Ductal HyperplasiaDuctal Carcinoma in Situ
European Institute of Oncology 300
Testing effectiveness (Phase 2)UnknownNCT04767620
What this trial is testing

Clinical Trial of Ruxian Zengsheng No. 1 Decoction

Who this might be right for
Mammary Gland Hyperplasia
Jiuda Zhao 137
Testing effectiveness (Phase 2)Looking for participantsNCT06195306
What this trial is testing

Low Dose Tamoxifen With or Without Omega-3 Fatty Acids for Breast Cancer Risk Reduction

Who this might be right for
Breast Atypical HyperplasiaBreast CarcinomaBreast Ductal Carcinoma In Situ+1 more
National Cancer Institute (NCI) 66
Not applicableStudy completedNCT01874184
What this trial is testing

Group-Based Lifestyle Intervention in Measuring Biomarker Levels in Participants at High Risk for Breast Cancer

Who this might be right for
Atypical Ductal Breast HyperplasiaAtypical Lobular Breast HyperplasiaBRCA1 Mutation Carrier+3 more
University of Washington 17
Load More Results